Key facts
- Mirvie’s last known valuation is $178.7M (Aug 2025).
- It has raised $120.3M across 1 recorded rounds; the latest was Early Stage VC ($23.7M) in Jul 2025.
- Notable investors include General Catalyst, Khosla Ventures, GV, Correlation Ventures, Gates Foundation — 12 tracked in total.
- Mirvie has filed 1 Form D with the SEC, most recently Aug 2025 ($23.7M sold to 25 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Mirvie
Funding rounds
1 roundsAbout Mirvie
Developer of a medical diagnostic platform designed to make pregnancy safe by delivering information to moms and families. The company's platform facilitates predictive tests and therapeutic approaches with an early detection window to intervene before unexpected pregnancy complications, enabling medical practitioners to identify at-risk pregnancies and facilitate corrective actions.
- Sector
- Healthcare
- HQ
- South San Francisco, CA, United States
- Founded
- 2018
- Employees
- 49
- Website
- mirvie.com/
- Ownership
- Privately Held (backing)
Mirvie doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mirvie shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mirvie in its N-PORT filings yet. We sweep new filings monthly.